Literature DB >> 25359263

Adult-onset autosomal recessive ataxia associated with neuronal ceroid lipofuscinosis type 5 gene (CLN5) mutations.

Cecilia Mancini1, Stefano Nassani, Yiran Guo, Yulan Chen, Elisa Giorgio, Alessandro Brussino, Eleonora Di Gregorio, Simona Cavalieri, Nicola Lo Buono, Ada Funaro, Nicola Renato Pizio, Bruce Nmezi, Aija Kyttala, Filippo Maria Santorelli, Quasar Salem Padiath, Hakon Hakonarson, Hao Zhang, Alfredo Brusco.   

Abstract

Autosomal recessive inherited ataxias are a growing group of genetic disorders. We report two Italian siblings presenting in their mid-50s with difficulty in walking, dysarthria and progressive cognitive decline. Visual loss, ascribed to glaucoma, manifested a few years before the other symptoms. Brain MRI showed severe cerebellar atrophy, prevalent in the vermis, with marked cortical atrophy of both hemispheres. Exome sequencing identified a novel homozygous mutation (c.935G > A;p.Ser312Asn) in the ceroid neuronal lipofuscinosis type 5 gene (CLN5). Bioinformatics predictions and in vitro studies showed that the mutation was deleterious and likely affects ER-lysosome protein trafficking. Our findings support CLN5 hypomorphic mutations cause autosomal recessive cerebellar ataxia, confirming other reports showing CLN mutations are associated with adult-onset neurodegenerative disorders. We suggest CLN genes should be considered in the molecular analyses of patients presenting with adult-onset autosomal recessive cerebellar ataxia.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25359263     DOI: 10.1007/s00415-014-7553-y

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  24 in total

Review 1.  Genetic basis and phenotypic correlations of the neuronal ceroid lipofusinoses.

Authors:  Varun Warrier; Mariana Vieira; Sara E Mole
Journal:  Biochim Biophys Acta       Date:  2013-03-28

2.  Autosomal recessive spinocerebellar ataxia 7 (SCAR7) is caused by variants in TPP1, the gene involved in classic late-infantile neuronal ceroid lipofuscinosis 2 disease (CLN2 disease).

Authors:  Yu Sun; Rowida Almomani; Guido J Breedveld; Gijs W E Santen; Emmelien Aten; Dirk J Lefeber; Jorrit I Hoff; Esther Brusse; Frans W Verheijen; Rob M Verdijk; Marjolein Kriek; Ben Oostra; Martijn H Breuning; Monique Losekoot; Johan T den Dunnen; Bart P van de Warrenburg; Anneke J A Maat-Kievit
Journal:  Hum Mutat       Date:  2013-03-11       Impact factor: 4.878

3.  Early and late events induced by polyQ-expanded proteins: identification of a common pathogenic property of polYQ-expanded proteins.

Authors:  Alessandra Bertoni; Paola Giuliano; Mario Galgani; Deborah Rotoli; Luca Ulianich; Annagrazia Adornetto; Maria Rosaria Santillo; Antonio Porcellini; Vittorio Enrico Avvedimento
Journal:  J Biol Chem       Date:  2010-11-28       Impact factor: 5.157

4.  Adult neuronal ceroid lipofuscinosis with palmitoyl-protein thioesterase deficiency: first adult-onset patients of a childhood disease.

Authors:  O P van Diggelen; S Thobois; C Tilikete; M T Zabot; J L Keulemans; P A van Bunderen; P E Taschner; M Losekoot; Y V Voznyi
Journal:  Ann Neurol       Date:  2001-08       Impact factor: 10.422

5.  Kufs disease, the major adult form of neuronal ceroid lipofuscinosis, caused by mutations in CLN6.

Authors:  Todor Arsov; Katherine R Smith; John Damiano; Silvana Franceschetti; Laura Canafoglia; Catherine J Bromhead; Eva Andermann; Danya F Vears; Patrick Cossette; Sulekha Rajagopalan; Alan McDougall; Vito Sofia; Michael Farrell; Umberto Aguglia; Andrea Zini; Stefano Meletti; Michela Morbin; Saul Mullen; Frederick Andermann; Sara E Mole; Melanie Bahlo; Samuel F Berkovic
Journal:  Am J Hum Genet       Date:  2011-05-05       Impact factor: 11.025

6.  The neuronal ceroid lipofuscinosis protein CLN5: new insights into cellular maturation, transport, and consequences of mutations.

Authors:  Mia-Lisa Schmiedt; Carlos Bessa; Claudia Heine; Maria Gil Ribeiro; Anu Jalanko; Aija Kyttälä
Journal:  Hum Mutat       Date:  2010-03       Impact factor: 4.878

Review 7.  Cell biology and function of neuronal ceroid lipofuscinosis-related proteins.

Authors:  Katrin Kollmann; Kristiina Uusi-Rauva; Enzo Scifo; Jaana Tyynelä; Anu Jalanko; Thomas Braulke
Journal:  Biochim Biophys Acta       Date:  2013-02-09

8.  CLN5, a novel gene encoding a putative transmembrane protein mutated in Finnish variant late infantile neuronal ceroid lipofuscinosis.

Authors:  M Savukoski; T Klockars; V Holmberg; P Santavuori; E S Lander; L Peltonen
Journal:  Nat Genet       Date:  1998-07       Impact factor: 38.330

9.  Revelation of a novel CLN5 mutation in early juvenile neuronal ceroid lipofuscinosis.

Authors:  N Cannelli; N Nardocci; D Cassandrini; M Morbin; C Aiello; M Bugiani; L Criscuolo; F Zara; P Striano; T Granata; E Bertini; A Simonati; F M Santorelli
Journal:  Neuropediatrics       Date:  2007-02       Impact factor: 1.947

10.  Exome-sequencing confirms DNAJC5 mutations as cause of adult neuronal ceroid-lipofuscinosis.

Authors:  Bruno A Benitez; David Alvarado; Yefei Cai; Kevin Mayo; Sumitra Chakraverty; Joanne Norton; John C Morris; Mark S Sands; Alison Goate; Carlos Cruchaga
Journal:  PLoS One       Date:  2011-11-04       Impact factor: 3.240

View more
  11 in total

Review 1.  Genetic landscape remodelling in spinocerebellar ataxias: the influence of next-generation sequencing.

Authors:  Marie Coutelier; Giovanni Stevanin; Alexis Brice
Journal:  J Neurol       Date:  2015-04-11       Impact factor: 4.849

2.  The Neuronal Ceroid Lipofuscinoses-Linked Loss of Function CLN5 and CLN8 Variants Disrupt Normal Lysosomal Function.

Authors:  Shaho Parvin; Maryam Rezazadeh; Hassan Hosseinzadeh; Mohsen Moradi; Shadi Shiva; Jalal Gharesouran
Journal:  Neuromolecular Med       Date:  2019-03-27       Impact factor: 3.843

3.  Autosomal recessive adult onset ataxia.

Authors:  Nataša Dragašević-Mišković; Iva Stanković; Andona Milovanović; Vladimir S Kostić
Journal:  J Neurol       Date:  2021-09-09       Impact factor: 4.849

Review 4.  Therapeutic landscape for Batten disease: current treatments and future prospects.

Authors:  Tyler B Johnson; Jacob T Cain; Katherine A White; Denia Ramirez-Montealegre; David A Pearce; Jill M Weimer
Journal:  Nat Rev Neurol       Date:  2019-03       Impact factor: 42.937

Review 5.  A lysosomal enigma CLN5 and its significance in understanding neuronal ceroid lipofuscinosis.

Authors:  I Basak; H E Wicky; K O McDonald; J B Xu; J E Palmer; H L Best; S Lefrancois; S Y Lee; L Schoderboeck; S M Hughes
Journal:  Cell Mol Life Sci       Date:  2021-04-01       Impact factor: 9.261

6.  Brain imaging in Kufs disease type B: case reports.

Authors:  Roberto Di Fabio; Claudio Colonnese; Filippo Maria Santorelli; Liliana Pestillo; Francesco Pierelli
Journal:  BMC Neurol       Date:  2015-07-04       Impact factor: 2.474

7.  Induced Pluripotent Stem Cells Derived from a CLN5 Patient Manifest Phenotypic Characteristics of Neuronal Ceroid Lipofuscinoses.

Authors:  Kristiina Uusi-Rauva; Tea Blom; Carina von Schantz-Fant; Tomas Blom; Anu Jalanko; Aija Kyttälä
Journal:  Int J Mol Sci       Date:  2017-05-01       Impact factor: 5.923

8.  Loss of Cln5 causes altered neurogenesis in a mouse model of a childhood neurodegenerative disorder.

Authors:  Ekaterina Savchenko; Yajuvinder Singh; Henna Konttinen; Katarina Lejavova; Laura Mediavilla Santos; Alexandra Grubman; Virve Kärkkäinen; Velta Keksa-Goldsteine; Nikolay Naumenko; Pasi Tavi; Anthony R White; Tarja Malm; Jari Koistinaho; Katja M Kanninen
Journal:  Dis Model Mech       Date:  2017-07-21       Impact factor: 5.758

Review 9.  Recent Insights into NCL Protein Function Using the Model Organism Dictyostelium discoideum.

Authors:  Meagan D McLaren; Sabateeshan Mathavarajah; Robert J Huber
Journal:  Cells       Date:  2019-02-02       Impact factor: 7.666

10.  Australian Cattle Dogs with Neuronal Ceroid Lipofuscinosis are Homozygous for a CLN5 Nonsense Mutation Previously Identified in Border Collies.

Authors:  A Kolicheski; G S Johnson; D P O'Brien; T Mhlanga-Mutangadura; D Gilliam; J Guo; T D Anderson-Sieg; R D Schnabel; J F Taylor; A Lebowitz; B Swanson; D Hicks; Z E Niman; F A Wininger; M C Carpentier; M L Katz
Journal:  J Vet Intern Med       Date:  2016-05-20       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.